University of Maryland Greenebaum Cancer Center
22 South Greene Street
Baltimore, MD 21201
800-888-8823
800-735-2258
General Website http://www.umgcc.org/
Related Articles:
- Beacon NewsFlashes – July 11, 2011
- MDS Patients’ Pretreatment Risk Level Predicts Outcome Of Vidaza Treatments (EHA 2009)
- Revlimid Use In MDS May Not Increase Risk Of Additional Cancers (ASH 2011)
- Vidaza Or Dacogen Treatment May Be Effective In MDS Patients Before Stem Cell Transplantation (EHA 2010)
- Beacon NewsFlashes – June 2, 2011